trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Storing body fat around the abdomen rather than the hips is associated with a higher risk for heart disease and type 2 diabetes.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that storing body fat around the abdomen rather than the hips is associated with a higher risk for heart disease and type 2 diabetes?

Yes. Storing excess body fat primarily around the abdomen rather than the hips is a well-established risk factor for cardiovascular disease and metabolic complications such as type 2 diabetes.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The claim is a specific, well-established medical consensus regarding fat distribution and cardiometabolic risk. Several retrieved papers explicitly discuss abdominal or visceral adiposity as a core component of metabolic syndrome, cardiovascular disease screening, and metabolic risk staging.

Evidence for · 3
Clinical Assessment of Obesity Beyond Body Mass Index: Adiposity Evaluation, Body-Composition Phenotyping and Disease Staging: A Narrative Review.
2026
The review notes that anthropometric indices help evaluate abdominal adiposity and its associated cardiometabolic risk.
Get citation
IV, U., A, A., S, L., A, B., L, G., B, T., & A, S. (2026). Clinical Assessment of Obesity Beyond Body Mass Index: Adiposity Evaluation, Body-Composition Phenotyping and Disease Staging: A Narrative Review.. doi.org. https://doi.org/10.3390/diagnostics16172837

See more details
More for · 2
Unraveling the Metabolic-Cardiovascular Disease Nexus: An Epidemiological Network Analysis Identifies Central Indicators.
2026
The network analysis identifies abdominal obesity as a central indicator for cardiovascular disease screening and metabolic disorders.
Get citation
XY, C., JF, Z., H, H., W, T., Q, L., Y, S., XX, Z., QC, C., J, Z., YQ, S., & T, L. (2026). Unraveling the Metabolic-Cardiovascular Disease Nexus: An Epidemiological Network Analysis Identifies Central Indicators.. doi.org. https://doi.org/10.1002/mco2.70967

Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review.
2026
The review highlights central (abdominal) obesity as a defining core component of metabolic syndrome and cardiometabolic risk.
Get citation
V, E., DC, P., B, M., M, D., & AC, N. (2026). Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review.. doi.org. https://doi.org/10.3390/medicina62091742

What does the evidence say?

The claim is a specific, well-established medical consensus regarding fat distribution and cardiometabolic risk. Several retrieved papers explicitly discuss abdominal or visceral adiposity as a core component of metabolic syndrome, cardiovascular disease screening, and metabolic risk staging.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work